Pfizer and Moderna ramp up EU Covid vaccine prices

"At least 97% of the funding for the development of the Oxford/AstraZeneca Covid-19 vaccine has been identified as coming from taxpayers or charitable trusts [..] Oxford University initially said any vaccine it developed would be open to qualified manufacturers to produce without paying royalties, and priced either at cost or at a small profit. However, by August 2020, reportedly at the urging of the Bill & Melinda Gates Foundation, among others, the university decided to change course. It entered an exclusive licensing agreement with the British-Swedish drugmaker AstraZeneca." - https://www.theguardian.com/science/2021/apr/15/oxfordastraz...

I'd like to see a similar analysis made for the Pfizer and Moderna vaccines.

Given how the EU treated AstraZeneca, it makes sense that other companies would price in the expected risk of doing business with the EU.

Read the room, Pfizer and Moderna, this move will backfire in a big way if they go through with it.

It's called 'A captive market'.